Specifically, it prompts us to investigate whether Atox1 activity is altered in response to cytostatic and cytotoxic effects and whether it contributes to the regulation of the survival-death balance in tumor cells, particularly those harboring p53-null mutations. This evidence concerns the gene TP53 and neoplasm.